Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Abdalla, Benito Cadenas-Noreña, Miguel Ángel Calleja, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrándiz, Juan Oliva-Moreno, José Luis Trillo, Álvaro Hidalgo-Vega
OBJECTIVES: The aim of this study was to review the current evaluation and funding processes for new drugs in different developed countries, to provide a comparative framework with detailed, homogeneous, and up-to-date information. METHODS: Scientific publications, reports and websites were reviewed between July and December 2021 using PubMed, Google Scholar, and grey literature sources. The main items searched were actors and processes, including timelines, characteristics of clinical and economic evaluations, participation of stakeholders, elements of price and reimbursement decisions, cost-effectiveness thresholds and specific funds...
January 12, 2024: Applied Health Economics and Health Policy